Moderna gains as Arbutus/ Genevant settlement removes major financial risk

2026-03-04 09:18:05 ET

More on Moderna, Arbutus Biopharma, etc.

• Roivant Sciences Ltd. (ROIV) Discusses $2.25 Billion Global Settlement Resolving COVID Vaccine Patent Litigation Transcript
• Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Roivant Sciences Ltd. (ROIV) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Moderna surges after hours on patent settlement with Arbutus and Genevant
• Pfizer-backed Priovant wins FDA priority review for lead asset

Read the full article on Seeking Alpha

For further details see: